Global Epigenetics Market
Dublin, Dec. 06, 2022 (GLOBE NEWSWIRE) -- The "Epigenetics Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
The global epigenetics market was valued at $1,018.1 million in 2020, and is projected to reach $4,056.86 million by 2030, registering a CAGR of 14.8% from 2021 to 2030.
The epigenetics market is expected to grow significantly during the forecast period, owing to rise in incidences of cancer and surge in its application in other chronic diseases such as cardiovascular disorders, metabolic diseases, infectious diseases, and inflammatory diseases. Increase in R&D activities, surge in investments in R&D, growth in epigenetic applications for non-oncology diseases, and increase in partnership between academic, pharmaceutical, and biotechnology companies significantly drive the market growth. However, high cost of instruments and lack of trained professionals impede the market growth.
Furthermore, untapped potential of emerging markets provides lucrative opportunities to the market players. Moreover, a rise in application of epigenetics processes underlying illness onset and progression has proven critical in recent years for creation of innovative early diagnostic and prognosis biomarkers for assessing patients and its utilization in precision medicine.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the epigenetics market analysis from 2020 to 2030 to identify the prevailing epigenetics market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the epigenetics market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global epigenetics market trends, key players, market segments, application areas, and market growth strategies.
No. of Pages
2020 - 2030
Estimated Market Value (USD) in 2020
Forecasted Market Value (USD) by 2030
Compound Annual Growth Rate
Key Market Segments
By End User
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Contrac Research Organizations
Rest of Europe
Rest of Asia-Pacific
Middle East And Africa
Key Market Players
Active Motif, Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific Inc.
Key Topics Covered:
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: EPIGENETICS MARKET, BY PRODUCT
CHAPTER 5: EPIGENETICS MARKET, BY APPLICATION
CHAPTER 6: EPIGENETICS MARKET, BY END USER
CHAPTER 7: EPIGENETICS MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
For more information about this report visit https://www.researchandmarkets.com/r/jinf50
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900